Raphaël Wisniewski
Chief Executive Officer at Axonics Europe SAS
Network origin in Raphaël Wisniewski first degree
Entity | Entity type | Industry | |
---|---|---|---|
Andera Partners SCA
Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France.
94
| Private Company | Investment Managers | 94 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom.
19
| Holding Company | Pharmaceuticals: Major | 19 |
18
| Public Company | Medical Specialties | 18 |
Public Company | Medical Specialties | 15 | |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France.
13
| Subsidiary | Medical/Nursing Services | 13 |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom.
12
| Subsidiary | Biotechnology | 12 |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands.
12
| Holding Company | Biotechnology | 12 |
SoniVie Ltd.
SoniVie Ltd. Medical SpecialtiesHealth Technology SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.
10
| Holding Company | Medical Specialties | 10 |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a "per patient, per setting" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ.
9
| Extinct | Pharmaceuticals: Major | 9 |
Grey Wolf Therapeutics Ltd.
Grey Wolf Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Grey Wolf Therapeutics Ltd. is a biotechnology company, which engages in the drug discovery in immuno-oncology. It targets endoplasmic reticulum aminopeptidases 1 and 2 in the antigen presentation pathway to drive modulation of the neoantigen repertoire on tumour cells. The company was founded by Thomas D. McCarthy and Peter Joyce and is headquartered in Oxford, the United Kingdom.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Raphaël Wisniewski via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
JOHNSON & JOHNSON | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor Private Equity Investor | |
Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Founder Private Equity Investor Private Equity Analyst | |
Altavia France SA
Altavia France SA Advertising/Marketing ServicesCommercial Services Altavia France SA is an investment holding company with interest in marketing and advertising sector. The company was founded on September 1, 1954 and is headquartered in Saint-Ouen-Sur-Seine, France. | Advertising/Marketing Services | Director/Board Member Director/Board Member | |
INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Masters Business Admin | |
Erasmus University Rotterdam | College/University | Doctorate Degree Masters Business Admin | |
University of Utrecht | College/University | Doctorate Degree Graduate Degree | |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
Katholieke Universiteit Leuven | College/University | Doctorate Degree Doctorate Degree | |
EM Lyon Business School | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
Université Paris Dauphine-PSL | College/University | Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
HEC Montréal | College/University | Undergraduate Degree Undergraduate Degree | |
ESSEC Business School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
ESCP Europe Campus Paris | College/University | Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
Complix NV
Complix NV Pharmaceuticals: MajorHealth Technology Complix NVengages in the development of biopharmaceutical company developing Alphabodies, a pipeline of transformative protein therapeutics. The Company is currently focusing its internal research and development activities on oncology and autoimmune diseases. Its therapeutic Alphabodies focuses on the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis and multiple sclerosis, and infectious diseases, and viral diseases such as influenza, HIV, and RSV. The company was founded by Mark Vaeck and Ignace Lasters in 2008 and is headquartered in Diepenbeek, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Passman SAS
Passman SAS Packaged SoftwareTechnology Services Passman SASU manufactures and designs digital solutions and telecommunication appliances. The firm's products include Wi-Fi access device, web corner, touch screen tablet, and electronic signage. The company was founded by Patrick Layani and Frederic Levy Valensi in 1995 and is headquartered in Villeurbanne, France. | Packaged Software | Director/Board Member Director/Board Member | |
Université Paris Nanterre | College/University | Graduate Degree Graduate Degree | |
Tuck School of Business at Dartmouth | College/University | Masters Business Admin Masters Business Admin | |
GamaMabs Pharma SA
GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member Chairman Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Nitinotes Ltd.
Nitinotes Ltd. Medical SpecialtiesHealth Technology Nitinotes Ltd. develops advance non-surgical bariatric solutions. The company was founded by Tamir Wolf and Irit Yaniv in 2014 and is headquartered in Ramat Gan, Israel. | Medical Specialties | Founder Director/Board Member | |
Walor International SAS
Walor International SAS Metal FabricationProducer Manufacturing Walor International SAS manufactures precision machine components for the automotive industry. Its expertise includes cold forging, machining, and thermal treatment. The company was founded by Jacky Lorin and Jim Wallart in June 1993 and is headquartered in Lege, France. | Metal Fabrication | Director/Board Member Director/Board Member | |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
PHARVARIS N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ellisphère SAS
Ellisphère SAS Data Processing ServicesTechnology Services Ellisphère SAS develops and provides data science and analytics solutions. It specializes in the collection and processing of financial, economic, and legal information for investment professional. The company was founded in 2006 and is headquartered in Nanterre, France. | Data Processing Services | Director/Board Member Director/Board Member | |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman Chairman | |
Naitways SAS
Naitways SAS Information Technology ServicesTechnology Services Naitways SAS is a French company that provides customized infrastructure services to improve efficiency, security, and agility. The company is based in Boulogne-Billancourt, France. The company's team of experts assists clients in managing and evolving their infrastructure. | Information Technology Services | Director/Board Member Director/Board Member | |
G3S Alyzia SAS
G3S Alyzia SAS Financial ConglomeratesFinance G3s Alyzia SASU operates as a holding company with interests in facility management and cleaning services. The company is headquartered in Ramonville-Saint-Agne, France. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Founder | |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Pathios Therapeutics Ltd. engages in discovering and developing novel small molecule drugs. The company was founded by Thomas David McCarthy, Alan Naylor, Kirsty McCarthy, Peter Joyce and Someit Sidhu in 2017 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Founder Founder Founder | |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Egle Therapeutics SAS
Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Chairman Chief Executive Officer Director/Board Member | |
Escp Business School | College/University | Graduate Degree Graduate Degree | |
Synacktiv SAS
Synacktiv SAS Information Technology ServicesTechnology Services Synacktiv SAS provides cyber security services. The company is based in Paris, France. The French company was founded in 2012 by Nicolas Collignon, Renaud Feil. Renaud Feil has been the CEO since 2012. | Information Technology Services | Director/Board Member Director/Board Member Director/Board Member | |
EQT Life Sciences Group BV
EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Upstream Bio, Inc.
Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
ValCare Medical, Inc.
ValCare Medical, Inc. Medical SpecialtiesHealth Technology ValCare Medical, Inc. engages in the designing, developing and commercializing devices and accessories for minimally invasive treatment of heart valve diseases. The firm develops a unique transcatheter device, which will provide the capability to implant the mitral annuloplasty device interventionally without surgery. The company was founded by Samuel M. Shaolian in 2012 and is headquartered in Herzlyia Pituach, Israel. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member |
Statistics
International
France | 20 |
United States | 12 |
Netherlands | 8 |
Israel | 4 |
Belgium | 4 |
Sectoral
Health Technology | 19 |
Consumer Services | 17 |
Finance | 6 |
Commercial Services | 5 |
Technology Services | 5 |
Operational
Director/Board Member | 472 |
Corporate Officer/Principal | 128 |
Private Equity Investor | 81 |
Chairman | 76 |
Chief Executive Officer | 71 |
Most connected contacts
Insiders | |
---|---|
Pierre Legault | 45 |
Barbara Dalton | 35 |
Martijn Kleijwegt | 33 |
Chen-Ming Yu | 33 |
Brent Ahrens | 30 |
Chris Mirabelli | 29 |
Moshe Arkin | 29 |
Rémi Droller | 29 |
Raymond Cohen | 28 |
Florent Gros | 28 |
Irit Yaniv | 27 |
Edward L. Erickson | 20 |
Gilles Nobécourt | 19 |
Jan Groen | 19 |
Thierry Hercend | 18 |
- Stock Market
- Insiders
- Raphaël Wisniewski
- Company connections